TransEnterix Inc. | Ownership
Companies that own TransEnterix Inc.
BlackRock Fund Advisors
9,093,789
4.34%
7,355,705
0%
06/30/2018
The Vanguard Group, Inc.
7,154,761
3.42%
1,559,203
0%
06/30/2018
JPMorgan Asset Management (UK) Ltd.
4,582,291
2.19%
-733,975
0.02%
06/30/2018
SSgA Funds Management, Inc.
3,294,763
1.58%
3,173,811
0%
06/30/2018
Global X Management Co. LLC
2,571,476
1.23%
2,571,476
0.16%
06/30/2018
JPMorgan Investment Management, Inc.
2,222,478
1.06%
376,500
0%
06/30/2018
Artemis Investment Management LLP
1,315,072
0.63%
1,315,072
0.03%
06/30/2018
Masters Capital Management LLC
1,236,505
0.59%
-2,763,495
1.13%
06/30/2018
RBC Capital Markets LLC (Investment Management)
1,217,862
0.57%
71,570
0.02%
06/30/2018
Geode Capital Management LLC
1,157,848
0.55%
487,688
0%
06/30/2018
| Address |
635 Davis Drive
Morrisville North Carolina 27560
United States
|
|
Employees
|
- |
| Website |
http://www.transenterix.com |
| Updated |
07/08/2019 |
| TransEnterix, Inc. operates as a development stage medical device company. It focuses on research, development and sale of medical device robotics to improve minimally invasive surgery. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform. |
